NICE recommends cenobamate for treatment of adult epilepsy patients in UK by Lucy Parsons | Nov 15, 2021 | News | 0 Epilepsy affects over 600,000 people in the UK, which is approximately one in every 100 people Read More
Ontozry scores MHRA authorisation for focal-onset seizures by Lucy Parsons | Jun 17, 2021 | News | 0 Drug approved to treat adult patients with epilepsy which has not been adequately controlled with at least two anti-epileptic therapies Read More
EC approval for Ontozry by Selina McKee | Apr 6, 2021 | News | 0 The drug offers new hope for epilepsy patients with focal-onset seizures Read More